23andMe Holding Co. (ME) Financial Statements (2025 and earlier)

Company Profile

Business Address 223 N. MATHILDA AVE.
SUNNYVALE, CA 94086
State of Incorp.
Fiscal Year End March 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2024
Q2
6/30/2024
Q1
3/31/2024
Q4
12/31/2023
Q3
9/30/2023
Q2
6/30/2023
Q1
3/31/2023
Q4
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments169,971 242,418256,386314,351386,849
Cash and cash equivalents169,971 242,418256,386314,351386,849
Restricted cash and investments1,499 1,3991,3991,3991,399
Receivables3,637 24,0211,5014,1241,897
Inventory, net of allowances, customer advances and progress billings14,747 15,66614,97911,81510,247
Inventory14,747 15,66614,97911,81510,247
Prepaid expense11,771 11,454   
Deferred costs5,046 12,2225,7827,3015,376
Other current assets2,155 2,779   
Other undisclosed current assets24,128  17,94821,28619,224
Total current assets:232,954 309,959297,995360,276424,992
Noncurrent Assets
Operating lease, right-of-use asset47,016 50,73852,54954,32956,078
Property, plant and equipment26,620 30,27032,80535,70438,608
Intangible assets, net (including goodwill)31,275 188,178389,579393,422397,264
Goodwill   152,944351,744351,744351,744
Intangible assets, net (excluding goodwill)31,275 35,23437,83541,67845,520
Restricted cash and investments8,974 6,9746,9746,9746,974
Other noncurrent assets1,140 2,2652,3572,6123,021
Other undisclosed noncurrent assets20,068 19,82718,97117,88215,661
Total noncurrent assets:135,093 298,252503,235510,923517,606
TOTAL ASSETS:368,047 608,211801,230871,199942,598
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities75,865 55,29053,23262,96379,354
Accounts payable11,192 13,1668,54612,74812,924
Accrued liabilities64,673 42,12444,68650,21566,430
Deferred revenue68,015 80,46840,28348,12362,521
Restructuring reserve  131   
Other undisclosed current liabilities8,977 8,2508,0867,8237,541
Total current liabilities:152,857 144,139101,601118,909149,416
Noncurrent Liabilities
Liabilities, other than long-term debt71,686 86,88474,37876,80079,243
Deferred revenue 5,000 15,000   
Other liabilities1,500 1,4431,4151,3881,480
Operating lease, liability65,186 70,44172,96375,41277,763
Total noncurrent liabilities:71,686 86,88474,37876,80079,243
Total liabilities:224,543 231,023175,979195,709228,659
Equity
Equity, attributable to parent143,504 377,188625,251675,490713,939
Common stock51 48484746
Additional paid in capital2,385,941 2,341,3942,311,4812,287,4052,220,897
Accumulated other comprehensive loss     (954)(620)
Accumulated deficit(2,242,488) (1,964,254)(1,686,278)(1,611,008)(1,506,384)
Total equity:143,504 377,188625,251675,490713,939
TOTAL LIABILITIES AND EQUITY:368,047 608,211801,230871,199942,598

Income Statement (P&L) ($ in thousands)

9/30/2024
Q2
6/30/2024
Q1
3/31/2024
Q4
12/31/2023
Q3
9/30/2023
Q2
6/30/2023
Q1
3/31/2023
Q4
Revenues40,414 44,74749,99960,86492,377
Cost of revenue(19,900) (24,811)(28,270)(30,184)(52,395)
Gross profit:20,514 19,93621,72930,68039,982
Operating expenses(92,469) (301,146)(100,860)(139,944)(109,256)
Operating loss:(71,955) (281,210)(79,131)(109,264)(69,274)
Nonoperating income (expense)(19) 23145333174
Loss from continuing operations before equity method investments, income taxes:(71,974) (281,187)(78,986)(108,931)(69,100)
Other undisclosed income from continuing operations before income taxes2,574 3,2303,7524,3074,369
Loss from continuing operations before income taxes:(69,400) (277,957)(75,234)(104,624)(64,731)
Income tax expense (benefit)  (19)(36) 633
Net loss available to common stockholders, diluted:(69,400) (277,976)(75,270)(104,624)(64,098)

Comprehensive Income ($ in thousands)

9/30/2024
Q2
6/30/2024
Q1
3/31/2024
Q4
12/31/2023
Q3
9/30/2023
Q2
6/30/2023
Q1
3/31/2023
Q4
Net loss:(69,400) (277,976)(75,270)(104,624)(64,098)
Other comprehensive income (loss)    954(334)(309)
Comprehensive loss, net of tax, attributable to parent:(69,400) (277,976)(74,316)(104,958)(64,407)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: